celebrating

20 years

of transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care

5 Ways We’re Innovating the Digital Experience for Claims Professionals

Claims professionals have long been the frontline of claims management – this has not changed. What has changed is just about everything else.
Read More

The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by coronavirus may face long-term health complications, potentially complicating workers' comp claims
Read More

2021 Industry Insights Survey Report

We surveyed 600+ workers’ comp professionals on the biggest industry disruptors and priorities.
Read More

Personalize my experience

Make selections below to see articles and information related to your role and interests.
  • I am a

  • I'm interested in

Healthesystems at NWCDC 2018

Join our VP of Clinical Services on December 6th in Las Vegas for a presentation on value-based care in workers’ comp.

Nov 2018

DEA Reschedules Epidiolex

The marijuana-derived seizure drug now sits at schedule V, facing far fewer prescribing and dispensing restrictions.

Oct 2018

Dr. Silvia Sacalis Discusses Medication Red Flags with Risk & Insurance

Healthesystems’ VP of Clinical Services offers insight into prescriptions in workers’ comp claims that should raise concerns.

Oct 2018

New Jersey Bill Pushes for Medical Marijuana Reimbursement

Assembly No. 4505 may solidify precedence recently made by a judge from the Division of Workers’ Compensation.

Oct 2018

National Safety Council Issues Report on Workplace Fatigue

Common risk factors can increase worker fatigue, leading to more frequent workplace injuries and a loss of productivity.

Oct 2018

Federal Opioid Reform Bill Signed into Law

With an enormous range of initiatives to prevent and treat opioid use disorder, the bill has officially been signed by the President.

Oct 2018

FDA Approves New Dosage for Opioid Dependence Therapy

Cassipa (buprenorphine and naloxone) sublingual film delivers a new dosage for the treatment of opioid dependence.

Sep 2018

Dr. Silvia Sacalis Discusses Polypharmacy with WC Magazine

Healthesystems’ VP of Clinical Services explains how too many drugs in a claim can cause health concerns, and what can be done to prevent them.

Sep 2018

FDA Reassesses Opioid Policies

The FDA is working to create new opioid prescribing practices and guidelines, while also shifting drug development priorities for pain medications.

Sep 2018

CWCI Releases Polypharmacy Report

According to 2016-2017 data, over 20% of polypharmacy claims are over 10 years old, with more than 50% of them for patients aged 50 and older.

Sep 2018

Massachusetts Study Links Occupation to Opioid Overdose Deaths

On average, construction workers are six times more likely to die from an opioid overdose death, more than any other occupation.

Sep 2018

Dr. Robert Goldberg Comments on DEA Opioid Manufacturing Quotas

Healthesystems’ Chief Medical Officer spoke with WorkCompCentral regarding DEA plans to reduce opioid manufacturing.

Sep 2018

FDA Accepts New Drug Application for Opioid NKTR-181

NKTR-181 is supposed to offer a lower frequency of opioid side effects. But are more opioids really the solution we need to the opioid crisis?

Aug 2018

Sandy Shtab Discusses the Need to Modernize Regulation with WorkCompWire

Healthesystems’ AVP of Advocacy & Compliance explains how regulation has been unable to keep pace with healthcare innovation & technology.

Aug 2018

PTSD Legislation Continues to Grow

More states cover PTSD without physical injuries for first responders, and 24 states allow PTSD patients to use medical marijuana.

Aug 2018

New Developments in Migraine Medications

A new wave of drugs that suppress CGRP proteins to reduce migraines could be on the horizon.

Aug 2018

FDA Proposes New Clinical Endpoints for Development of Opioid-Use Disorder Drugs

Drugs to treat opioid dependence could be approved under new clinical endpoints other than reducing opioid use.

Aug 2018

Healthe Clinical Leaders in the News

Our Chief Medical Officer and VP of Clinical Services comment on matters such as the use of anticonvulsants to treat pain and opioid prescriptions for inpatients.

Aug 2018

New Opioid in Development May Offer Reduced Risk Profile

Phase 2/3 clinical trial results for Korsuva demonstrate pain relief with fewer side effects.

Jul 2018

Mark of the Millennial: Managed Care for a New Generation

Millennials are more diverse and more open to alternative therapies, medical marijuana, healthcare technology, and dialogue surrounding psychosocial concerns.

Jul 2018

Support for Marijuana Continues to Grow Across the Nation

A flurry of recent developments continues to bring the medical marijuana debate front and center, including further legalization, a Senate bill, a drug approval, and more.

Jul 2018

JAMA Study Questions the Effectiveness of Negative Pressure Wound Therapy

In a randomized clinical trial of 460 patients, researchers found the treatment to have similar impact on self-rated disability as standard wound dressing.

Jul 2018

Healthesystems at WCIEC Orlando 2018

Visit Healthesystems in booth #914 to see how we explore the conference’s “Cosmic” theme, and for a chance to win a $250 gift card.

Jul 2018

Drug Approvals Impacting Workers’ Comp

The FDA recently approved drugs to treat opioid dependence, migraines, and rheumatoid arthritis.

Jun 2018

The Burden of Opioid-Related Mortality in the United States

Among many findings, JAMA reports that 20% of deaths among those aged 25-34 were opioid-related.

Jun 2018

More States Pass Opioid Prescription Limits

Within the last month, laws have passed in Tennessee, Colorado, South Carolina, Oklahoma, and Hawaii.

Jun 2018

IQVIA Reports on Global Oncology Trends

Global spending on cancer therapies now exceeds $133 billion.

Jun 2018

Healthe Leaders Comment on Clinical Use of Marijuana & MDMA

Our Chief Medical Officer and VP of Clinical Services comment on the clinical use of ecstasy and marijuana.

Jun 2018

FDA Encourages Drug Developers to Focus on Buprenorphine Depot Products

A newly released draft guidance encourages the development of more sustained-release buprenorphine products.

May 2018

WCRI Releases CompScope Benchmarks

In-depth reports for 16 different states examine medical payments, costs, duration of disability, and more.

May 2018

1 2 3 4 5 9 10 11 12 13
lockenvelopephone-handsetmenuarrow-rightcross-circle